| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |